Asociación entre tiroiditis linfocítica crónica y carcinoma papilar de tiroides: Revisión sistemática y metaanálisis de estudios en especímenes quirúrgicos

Autores/as

DOI:

https://doi.org/10.30944/20117582.2228

Palabras clave:

carcinoma papilar de tiroides, tiroiditis linfocítica crónica, especímenes quirúrgicos, estudio retrospectivo, revisión sistemática, metaanálisis

Resumen

Introducción. Existen resultados inconsistentes con relación al planteamiento de la hipótesis que sugiere una mayor probabilidad de documentar un carcinoma papilar de tiroides en especímenes quirúrgicos con cambios compatibles con tiroiditis linfocítica crónica. En los metaanálisis se han incluido estudios no comparables metodológicamente y no se proponen claras fuentes de sesgo, justificación para la realización del presente estudio.

Métodos. Se realizó una búsqueda bibliográfica en PubMed y Embase. Fueron obtenidos estudios retrospectivos donde se comparaba la prevalencia de carcinoma papilar de tiroides en especímenes con y sin cambios por tiroiditis linfocítica crónica. La evidencia recolectada fue sintetizada estadísticamente.

Resultados. Un total de 22 artículos fueron incluidos. La población estuvo conformada por 63.548 especímenes. El OR combinado fue 1,81 (IC95%: 1,51-2,21). Hubo heterogeneidad en la distribución de las razones de oportunidad entre los estudios (I2 = 91 %; p>0,00001). La forma del gráfico en embudo de los estudios incluidos en el análisis parece estar simétrica, lo que indica la ausencia del sesgo atribuible a los estudios pequeños.

Conclusiones. La literatura actual sugiere que existe un mayor riesgo de documentar un carcinoma papilar de tiroides en especímenes quirúrgicos en los que se observan cambios compatibles con tiroiditis linfocítica crónica; sin embargo, existen fuentes de sesgo que no será posible controlar en estudios retrospectivos, por lo que recomendamos estudiar la hipótesis que sugiere una mayor probabilidad de diagnosticar un carcinoma papilar de tiroides en especímenes con cambios compatibles con tiroiditis linfocítica crónica mediante metodologías prospectivas.

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Carlos Gustavo Osorio-Covo, Universidad de Cartagena

MD, General Surgeon, Department of General Surgery, Unit of Endocrine Surgery, Caribbean University Hospital. Professor, Scalpellum Research Group, Faculty of Medicine. Cartagena, Colombia.

Jorge Ballestas-Barrera, University of Cartagena. Cartagena, Colombia.

MD, General Surgery Undergraduate Student. Scalpellum Research Group, Faculty of Medicine. 

Juan Correa-Palacio, University of Cartagena. Cartagena, Colombia.

MD, General Surgery Undergraduate Student. Scalpellum Research Group, Faculty of Medicine.

Valeria Zambrano-Pacheco, University of Cartagena, Scalpellum Research Seedbed, Cartagena, Colombia.

Medical Student.

Angie Rosales-Becerra, University of Cartagena, Scalpellum Research Seedbed, Cartagena, Colombia.

Medical Student.

William Camargo-Martínez, University of Cartagena, Scalpellum Research Seedbed, Cartagena, Colombia.

Medical Student.

Diego Barrios-Castellar, University of Cartagena. Cartagena, Colombia.

MD, Scalpellum Research Group, Faculty of Medicine.

David Ortega-Caballero, University of Cartagena. Cartagena, Colombia.

MD, Scalpellum Research Group, Faculty of Medicine.

Francisco Herrera-Sáenz, University of Cartagena, Cartagena, Colombia.

MD, General Surgeon, Department of General Surgery, Unit of Endocrine Surgery, Caribbean University Hospital. Professor, Scalpellum Research Group, Faculty of Medicine.

Referencias bibliográficas

Rosai J, Albores Saavedra J, Asioli S, Baloch ZW, Bogdanova T, Chen H, et al. Papillary Thyroid Carcinoma. In: WHO Classification of Tumours of Endocrine Organs 4th edition. (Lloyd RV, Osamura RY, Klöppel G, Rosai J. eds.). IARC: Lyon; 2017. pp. 81-92.

Siegel R, Naishadham D, Jemal A. Cancer statistics 2013. CA Cancer J Clin. 2013;63:11-30. https://doi.org/10.3322/caac.21166

Soares P, Celestino R, Gaspar da Rocha A, Sobrinho-Simões M. Papillary thyroid microcarcinoma: ¿How to diagnose and manage this epidemic? Int J Surg Pathol. 2014;22:113-9. https://doi.org/10.1177/1066896913517394

Siegel RL, Miller KD, Fuch HE, Jemal A. Cancer statistics 2022. CA Cancer J Clin. 2022;72:7-33. https://doi.org/10.3322/caac.21708

Bongiovanni M, Giovanella L, Romanelli F, Trimboli P. Cytological diagnosis associated with noninvasive follicular thyroid neoplasms with papillary-like nuclear features according to the Bethesda system for reporting thyroid cytopathology: A systematic review and meta-analysis. Thyroid. 2019;29:222-8. https://doi.org/10.1089/thy.2018.0394

Caturegli P, De Remigis A, Rose N. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13:391-7. https://doi.org/10.1016/j.autrev.2014.01.007

Huber G, Staub JJ, Meier C, Mitrache C, Guglielmetti M, Huber P, et al. Prospective study of the espontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab. 2002;87:3221-6. https://doi.org/10.1210/jcem.87.7.8678

Zaletel K, Gaberscek S. Hashimoto´s thyroiditis: From genes to the disease. Curr Genomics. 2011;12:576-88. https://doi.org/10.2174/138920211798120763

Nosé V. Hashimoto Thyroiditis. In: Diagnostic Pathology: Endocrine. 2nd edition (Nosé V, Cipriani N, Fisch A, eds). Canadá: Elsevier Health Sciences; 2018; pp 53-60.

Lindsay S, Dailey ME, Friedlander J, Yee G, Soley MG. Chronic thyroiditis: a clinical and pathologic study of 354 patients. J Clin Endocrinol Metab. 1952;12:1578- 1600. https://doi.org/10.1210/jcem-12-12-1578

Dailey M, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg. 1955;70:291-7. https://doi.org/10.1001/archsurg.1955.01270080137023

Holm L, Blomgren H, Löwhagen T. Cancer risk in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985;312:601-4. https://doi.org/10.1056/NEJM198503073121001

Anil C, Goksel S, Gursoy A. Hashimoto’s thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid. 2010;20:601-6. https://doi.org/10.1089/thy.2009.0450

Le K, Hershman J. Hashimoto´s thyroiditis does not predispose patients to differentiated thyroid cancer. Clin Thyroidology. 2014;26:227-9. https://doi.org/10.1089/ct.2014;26.227-229

Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP. Coexistent Hashimoto’s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery. 1999;126:1070-7. https://doi.org/10.1067/msy.2099.101431

Lee JH, Kim Y, Choi JW, Kim YS. The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: a meta-analysis. Eur J Endocrinol. 2013;168:343-9. https://doi.org/10.1530/EJE-12-0903

Lai X, Xia Y, Zhang B, Li J, Jiang Y. A meta-analysis of Hashimoto’s thyroiditis and papillary thyroid carcinoma risk. Oncotarget. 2017;8:62414-24. https://doi.org/10.18632/oncotarget.18620

Resende de Paiva C, Grønhøj C, Feldt-Rasmussen U, von Buchwald C. Association between Hashimoto’s thyroiditis and thyroid cancer in 64,628 patients. Front Oncol. 2017;7:53. https://doi.org/10.3389/fonc.2017.00053

Jankovic B, Le K, Hershman J. Hashimoto’s thyroiditis and papillary thyroid carcinoma: is there a correlation? J Clin Endocrinol Metab. 2013;98:474-82. https://doi.org/10.1210/jc.2012-2978

Holm L, Blomgren H, Löwhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985;312:601-4. https://doi.org/10.1056/NEJM19850307312100

Gul K, Dirikoc A, Kiyak G, Ersoy P, Ugras N, Ersoy R, et al. The association between thyroid carcinoma and Hashimoto’s thyroiditis: the ultrasonographic and histopathologic characteristics of malignant nodules. Thyroid. 2010;20:873-8. https://doi.org/10.1089/thy.2009.0118

Alcântara-Jones D, Alcântara-Nunes T, Rocha B, Oliveira R, Santa A, Alcântara F, et al. Is there any association between Hashimoto’s thyroiditis and thyroid cancer? A retrospective data analysis. Radiol Bras. 2015;48:148-53. https://doi.org/10.1590/0100-3984.2014.0072

Matesa-Anić D, Matesa N, Dabelić N, Kusić Z. Coexistence of papillary carcinoma and Hashimoto’s thyroiditis. Acta Clin Croat. 2009;48:9-12.

Gómez J, Gómez N, Sahun M, Soler J. Prevalence and significance of lymphocyte infiltration in papillary carcinoma of the thyroid gland. Ann Med Int. 1997;14:403-5.

Asanuma K, Sugenoya A, Kasuga Y, Itoh N, Kobayashi S, Amano J. The relationship between multiple intrathyroidal involvement in papillary thyroid carcinoma and chronic non-specific thyroiditis. Cancer Lett. 1998;122:177-80. https://doi.org/10.1016/s0304-3835(97)00398-4

Loh K, Greenspan F, Dong F, Miller T, Yeo P. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 1999;84:458-63. https://doi.org/10.1210/jcem.84.2.5443

Kebebew E, Treseler P, Ituarte P, Clark O. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg. 2001;25:632-7. https://doi.org/10.1007/s002680020165

Tamimi D. The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol. 2002;10:141-6. https://doi.org/10.1177/106689690201000207

Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, et al. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg. 2005;71:874-8. https://doi.org/10.1177/000313480507101018

Del Rio P, Cataldo S, Sommaruga L, Kim Y. The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer? Minerva Endocrinologica. 2008;33:1-5.

Muzza M, Degl’Innocenti D, Colombo C, Perrino M, Elena R, Rossi S, et al. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf). 2010;72:702-8. https://doi.org/10.1111/j.1365-2265.2009.03699.x

Huang B, Hseuh C, Chao T, Lin K, Lin J. Well-differentiated thyroid carcinoma with concomitant Hashimoto’s thyroiditis present with less aggressive clinical stage and low recurrence. Endocr Pathol. 2011;22:144-9. https://doi.org/10.1007/s12022-011-9164-9

Yoon Y, Kim H, Lee J, Kim J, Koo B. The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngoly. 2012;269:1013-7. https://doi.org/10.1007/s00405-011-1732-6

Liberati A, Altman D, Tetzlaff J, Mulrow C, Gøtzsche P, Ioannidis J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. BMJ. 2009;339:b2700. https://doi.org/10.1136/bmj.b2700

Moher D, Liberati A, Tetzlaff J, Altman D, The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6:332-6. https://doi.org/10.1136/bmj.b2535

Dailey M, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg 1955;70:291-7. https://doi.org/10.1001/archsurg.1955.01270080137023

Okayasu I, Fujiwara M, Hara Y, Tanka Y, Rose N. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer. 1995;76:2312-8. https://doi.org/10.1002/1097-0142(19951201)76:1 13.0.co;2-h

Bradly DP, Reddy V, Prinz RA, Gattuso P. Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery 2009;146:1099-104. https://doi.org/10.1016/j.surg.2009.09.025

Consorti F, Loponte M, Milazzo F, Potasso L, Antonasi A. Risk of malignancy from thyroid nodular disease as an element of clinical management of patients with Hashimoto’s thyroiditis. Eur Surg Res 2010;45:333-7. https://doi.org/10.1159/000320954

Ahn D, Heo S, Park J, Kim J, Sohn J, Park J, et al. Clinical relationship between Hashimoto’s thyroiditis and papillary thyroid cancer. Acta Oncol 2011;50:1228-34. https://doi.org/10.3109/0284186X.2011.602109

Kim K, Park Y, Kim E, Park S, Park D, Ahn S, et al. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto’s thyroiditis. Head Neck. 2011;33:691- 5. https://doi.org/10.1002/hed.21518

Lun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z, et al. Hashimoto’s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol Head Neck Surg. 2013;148:396-402. https://doi.org/10.1177/0194599812472426

Kutluturk K, Unal B, Cetin S. Coexistence of Hashimoto’s thyroiditis with papillary thyroid carcinoma: a single center experience. J Turgut Ozal Med Cent. 2017;24:190-2. https://doi.org/10.5455/jtomc.2017.03.34

Lee I, Hsieh A, Lee T, Lee T, Chien Y. The association of thyrotropin and autoimmune thyroid disease in developing papillary thyroid cancer. Int J Endocrinol. 2017;2017:5940367. https://doi.org/10.1155/2017/5940367

Nawarathna N, Ratnayake P, Hewage S, Senevirathne J, Gunatilake S, Kariyawasam N, et al. Association between nonspecific chronic lymphocytic thyroiditis and differentiated epithelial thyroid carcinoma: Clinicopathological analysis of patients who underwent thyroidectomy in a tertiary care center in Sri Lanka. World J Endoc Surg. 2018;10:119-26. https://doi.org/10.5005/jp-journals-10002-1230

Jackson D, Handelsman R, Farrá J, Lew J. Increased incidental thyroid cancer in patients with subclinical chronic lymphocytic thyroiditis. J Surg Res. 2020;245:115-8. https://doi.org/10.1016/j.jss.2019.07.025

Peterson C, Shidler F. Lymphocytic thyroiditis in 757 thyroid operations. Am J Surg. 1957;94:223-31. https://doi.org/10.1016/0002-9610(57)90649-9

Shands W. Carcinoma of the thyroid in association with struma lymphomatosa (Hashimoto’s disease). Ann Surg. 1960;151:675-82. https://doi.org/10.1097/00000658-196005000-00008

Campos L, Picado S, Guimarães A, Ribeiro D, Dedivitis R. Thyroid papillary carcinoma associated to Hashimoto’s thyroiditis. Braz J Otorhinolaryngol. 2012;78:77-80. https://doi.org/10.5935/1808-8694.20120037

Yamashita H, Nakayama I, Noguchi S, Murakami N, Moriuchi A, Yokoyama S, et al. Thyroid carcinoma in benign thyroid diseases. An analysis from minute carcinoma. Acta Pathol Jpn. 1985;35:781-8. https://doi.org/10.1111/j.1440-1827.1985.tb00620.x

McLeod M, East M, Burney R, Harness J, Thompson N. Hashimoto’s thyroiditis revisited: the association with thyroid cancer remains obscure. World J Surg. 1988;12:509-6. https://doi.org/10.1007/BF01655435

Roberti A, Sobrinho J, Porto O, Rapoport A. Concomitância da tireoidite de Hashimoto e o carcinoma diferenciado da tireóide. Rev Col Bras Cir. 2006;33:345-9. https://doi.org/10.1590/S0100-69912006000600003

Kurukahvecioglu O, Taneri F, Yüksel O, Aydin A, Tezel E, Onuk E. Total thyroidectomy for the treatment of Hashimoto’s thyroiditis coexisting with papillary thyroid carcinoma. Adv Ther. 2007;24:510-6. https://doi.org/10.1007/BF02848773

Larson S, Jackson L, Riall T, Uchida T, Thomas R, Qiu S, et al. Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg. 2007;204:764-75. https://doi.org/10.1016/j.jamcollsurg.2006.12.037

Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H. Is Hashimoto’s thyroiditis a risk factor for papillary thyroid cancer? J Surg Res. 2008;150:49-52. https://doi.org/10.1016/j.jss.2007.09.020

Mazokopakis E, Tzortzinis A, Dalieraki-Ott E, Tsartsalis A, Syros P, Karefilakis C, et al. Coexistence of Hashimoto’s thyroiditis with papillary thyroid carcinoma. A retrospective study. Hormones (Athens). 2010;9:312-7. https://doi.org/10.14310/horm.2002.1282

Siriweera E, Ratnatunga N. Profile of Hashimoto’s thyroiditis in Sri Lankans: Is there an increased risk of ancillary pathologies in Hashimoto’s thyroiditis? J Thyroid Res. 2010;2010:124264. https://doi.org/10.4061/2010/124264

Buyukasik O, Hasdemir A, Yalcin E, Celep B, Sengul S, Yandakci K, et al. The association between thyroid malignancy and chronic lymphocytic thyroiditis: should it alter the surgical approach? Endokrynol Pol. 2011; 4:303-8.

Zhang L, Li H, Ji Q, Zhu Y,Wang Z, Wang Y,et al. The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease. BMC Cancer. 2012;12:610. https://doi.org/10.1186/1471-2407-12-610

Konturek A, Barczyński M, Wierzchowski W, Stopa M, Nowak W. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbecks Arch Surg. 2013;398:389-94. https://doi.org/10.1007/s00423-012-1021-x

Ye Z, Gu D, Hu H, Zhou Y, Hu X, Zhang X. Hashimoto’s thyroiditis, microcalcification and raised thyrotropin levels within normal range are associated with thyroid cancer. World J Surg Oncol. 2013;11:56. https://doi.org/10.1186/1477-7819-11-56

Giagourta I, Evangelopoulou C, Papaioannou G, Kassi G, Zapanti E, Prokopiou M, et al. Autoimmune thyroiditis in benign and malignant thyroid nodules: 16-year results. Head Neck. 2014;36:531-5. https://doi.org/10.1002/hed.23331

Liu X, Zhu L, Cui D, Wang Z, Chen H, Duan Y, et al. Coexistence of histologically confirmed Hashimoto’s thyroiditis with different stages of papillary thyroid carcinoma in a consecutive chinese cohort. Int J Endocrinol. 2014;2014:769294. https://doi.org/10.1155/2014/769294

Paparodis R, Imam S, Todorova-Koteva K, Staii A, Jaume J. Hashimoto’s thyroiditis pathology and risk for thyroid cancer. Thyroid. 2014;24:1107-14. https://doi.org/10.1089/thy.2013.0588

Zayed A, Ali M, Jaber O, Suleiman M, Ashhab A, Al Shweiat W, et al. Is Hashimoto’s thyroiditis a risk factor for medullary thyroid carcinoma? Our experience and a literature review. Endocrine. 2015;48:629-36. https://doi.org/10.1007/s12020-014-0363-2

Zhang Y, Ma X, Deng F, Liu Z, Wei H, Wang X, et al. The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer. World J Surg Oncol. 2014;12:277. https://doi.org/10.1186/1477-7819-12-277

Zhang Y, Dai J, Wu T, Yang N, Yin Z. The study of the coexistence of Hashimoto’s thyroiditis with papillary thyroid carcinoma. J Cancer Res Clin Oncol. 2014;140:1021-6. https://doi.org/10.1007/s00432-014-1629-z

Gabalec F, Srbova L, Nova M, Hovorkova E, Hornychova H, Jakubikova I, et al. Impact of Hashimoto’s thyroiditis, TSH levels, and anti-thyroid antibody positivity on differentiated thyroid carcinoma incidence. Endokrynol Pol. 2016;67:48-53. https://doi.org/10.5603/EP.a2016.0022

Liang J, Zeng W, Fang F, Yu T, Zhao Y, Fan X, et al. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients. Acta Otorhinolaryngol Ital. 2017;37:393-400. https://doi.org/10.14639/0392-100X-1709

Uhliarova B, Hajtman A. Hashimoto’s thyroiditis - an independent risk factor for papillary carcinoma. Braz J Otorhinolaryngol. 2018;84:729-35. https://doi.org/10.1016/j.bjorl.2017.08.012

Osorio C, Ibarra S, Arrieta J, Sarmiento M, Barrios D, Sierra L, et al. Association between chronic lymphocytic thyroiditis and papillary thyroid carcinoma: A retrospective study in surgical specimens. Rev Esp Patol. 2020;53:149-57. https://doi.org/10.1016/j.patol.2019.07.004

Publicado

2023-01-01

Cómo citar

(1)
Osorio-Covo, C.; Ballestas-Barrera, J.; Correa-Palacio, J.; Zambrano-Pacheco, V.; Rosales-Becerra, A.; Camargo-Martínez, W.; Barrios-Castellar, D.; Ortega-Caballero, D.; Herrera-Sáenz, F. Asociación Entre Tiroiditis linfocítica crónica Y Carcinoma Papilar De Tiroides: Revisión sistemática Y metaanálisis De Estudios En especímenes Quirúrgicos. Rev Colomb Cir 2023, 38, 37-49.

Número

Sección

Artículo Original
Crossref Cited-by logo

Métricas